DE:OMA Stock Latest News
Company AnnouncementsVivesto Appoints Nomination Committee for 2027 AGM4d ago
Company AnnouncementsVivesto Receives U.S. Orphan Drug Designation for Cantrixil in AML1w ago
Company AnnouncementsVivesto boosts Paccal Vet’s global profile with new oncology data at WSAVA 20261M ago
Company AnnouncementsVivesto’s Paccal Vet Data Spotlighted at Key Veterinary Oncology Conference1M ago
Company AnnouncementsVivesto’s Paccal Vet Shows Promising Efficacy and Safety in Feline Cancer Study2M ago
Company AnnouncementsVivesto’s Paccal Vet Shows Survival Benefit in Canine Hemangiosarcoma Study2M agoCompany AnnouncementsVivesto completes dog cancer trial recruitment as Paccal Vet nears key data readout4M ago
Company AnnouncementsVivesto completes dog enrollment in Paccal Vet hemangiosarcoma study ahead of Q3 data4M ago
Company AnnouncementsVivesto’s Cantrixil Clears Key Preclinical Hurdle With Positive i.v. Safety Data5M ago
Company AnnouncementsVivesto names seasoned life science financier Björn Svanström as new CFO5M ago
Company AnnouncementsVivesto Cuts Share Count After 1-for-100 Reverse Split5M ago

